The high diagnostic potential of the serum potassium/magnesium ratio for preeclampsia, with a specificity and sensitivity in the current study similar to that of the sFlt-1/PlGF ratio [5,20], makes it a potential candidate biomarker warranting further exploration for use in resource-limited resource settings and populations at risk. The gene discussed is PGF; the disease is preeclampsia.